http://www.igenericdrugs.com Review Rating: 100 out of 100 based on 897 reviews. 897 stars
Generic drugs
List of interchangeable brand and generic drugs
compare generic drug prices
 

Progynova 21

Search a suitable generic or branded drugs, if you could not find the prescribed medicine. This site does not supply any medicines. It contains prices for information purposes only.
You should consult a doctor about the dosage before using this medicine!

DRUG NAME:     

 

Progynova 21 uses and description

Sort by popularity
Progynova 21 - Pharmacology: Promotes growth and development of female reproductive system and secondary sex characteristics; affects release of pituitary gonadotropins; inhibits ovulation and prevents postpartum breast engorgement; conserves calcium and phosphorous and encourages bone formation; overrides stimulatory effects of testosterone.

Indication: Alora, Climara, Delestrogen, Depo-Estradiol, Divigel, Elestrin, Estrace tablets, Estraderm, Estrasorb, Estring, EstroGel, Evamist, Femring, Femtrace, Gynodiol, Vivelle, Vivelle-Dot

Treatment of moderate to severe vasomotor symptoms associated with menopause.

Alora, Climara, Delestrogen, Depo-Estradiol, Estraderm, Estrace tablets, Femtrace, Gynodiol, Vivelle, Vivelle-Dot

Treatment of hypoestrogenism due to hypogonadism.

Alora, Climara, Delestrogen, Estraderm, Estrace tablets, Gynodiol, Vivelle, Vivelle-Dot

Treatment of castration or primary ovarian failure.

Alora, Climara, Delestrogen, Depo-Estradiol, Estrace cream and tablets, Estraderm, Estring, EstroGel, Femring, Gynodiol, Vagifem, Vivelle, Vivelle-Dot

Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with menopause.

Alora, Climara, Estraderm, Gynodiol, Vivelle, Vivelle-Dot

Prevention of postmenopausal osteoporosis.

Delestrogen, Estrace tablets, Gynodiol

Treatment of advanced androgen-dependent carcinoma of the prostate (palliation only).

Estrace tablets, Gynodiol

Treatment of breast cancer in appropriately selected women and men with metastatic disease.

Used for: Treating conditions due to menopause (eg, hot flashes; vaginal itching, burning, or dryness), treating vulval or vaginal atrophy, and preventing osteoporosis (brittle bones). It is also used for estrogen replacement therapy after failure of the ovaries and to relieve the symptoms of breast cancer.

Treating advanced prostate cancer. It is also used to relieve symptoms of breast cancer.

Progynova 21 is a female estrogen hormone. It works by replacing natural estrogens in a woman who can no longer produce enough estrogen. It works for advanced prostate cancer by antagonizing male hormones.

Progynova 21, the principal intracellular human estrogen, is substantially more active than its metabolites, estrone and estriol, at the cellular level.

Indications:

Adult: PO Prostate cancer 10 mg 3 times/day for at least 3 mth. Menopausal vasomotor symptoms 1-2 mg/day on a cyclical or continuous regimen. Prevention of postmenopausal osteoporosis 0.5 mg/day in cyclical regimen. Hypogonadism 1-2 mg/day in a cyclic regimen. IM Prostate cancer As valerate: ≥30 mg 1-2 wkly. Menopausal vasomotor symptoms As cypionate: 1-5 mg 3-4 wkly. As valerate: 10-20 mg 4 wkly. Hypogonadism As valerate: 10-20 mg 4 wkly. Vag Vulvular and vag atrophy As cream: Insert 2-4 g/day for 2 wk.

Maintenance: 1 g 1-3 times/wk. Postmenopausal vag atrophy; Urogenital symptoms Per vag ring contains 2 mg: Insert a ring and keep in place for 90 days. Atrophic vaginitis Per tab contains 20 mcg: Insert 1 tab once daily for 2 wk.

Maintenance: 1 tab twice wkly. Attempt to discontinue or taper medication at 3-6 mthly intervals. Transdermal Menopausal vasomotor symptoms Per patch delivers 0.025 mg/day: Initial: Apply once wkly. Attempt to taper or discontinue treatment at 3-6 mth intervals. Prevention of postmenopausal osteoporosis Per patch delivers 14 mcg/day: Apply 1-2 times/wk.

Progynova 21 belongs to a group of female hormones known as estrogens. Progynova 21 is used as hormone replacement therapy (HRT) in menopausal women. It is used to treat menopausal symptoms such as hot flushes, vaginal dryness and itch. It is sometimes used in younger women when the ovaries fail to make enough estrogens.

Progynova 21 belongs to a group of female hormones known as estrogens. Progynova 21 Subcutaneous is sometimes also called Progynova 21 Implant. Progynova 21 Implant is used as hormone replacement therapy (HRT) in menopausal women. It is used to treat menopausal symptoms such as hot flushes, vaginal dryness and itch. It is also used to prevent osteoporosis in menopausal women.

Progynova 21 belongs to a group of female hormones known as estrogens. Progynova 21 is used as hormone replacement therapy (HRT) in menopausal women. It is used to treat menopausal symptoms such as hot flushes, vaginal dryness and itch. Progynova 21 is also used to prevent osteoporosis in menopausal women. It is sometimes used in younger women when the ovaries fail to make enough estrogens.

Progynova 21 belongs to a group of female hormones known as estrogens. Progynova 21 is used as hormone replacement therapy (HRT) in menopausal women. It helps to relieve vaginal symptoms caused by a shortage of estrogen in the body, such as vaginal itch, irritation or dryness. Progynova 21 Vaginal only relieves the vaginal symptoms of menopause. It does not relieve other symptoms such as hot flushes and mood changes.

Progynova 21 belongs to a group of female hormones known as estrogens. Progynova 21 is used as hormone replacement therapy (HRT) in menopausal women. It is used to treat menopausal symptoms such as hot flushes, vaginal dryness and itch. Progynova 21 is also used to prevent osteoporosis in menopausal women. It is sometimes used in younger women when the ovaries fail to make enough estrogens. Progynova 21 is also used to treat other hormonal problems and certain cancers.

Oral Prostate cancer

Adult: For androgen-dependent, inoperable and progressing cancer: 10 mg tid for at least 3 mth. Oral Moderate to severe vasomotor symptoms associated with menopause

Adult: 1-2 mg/day adjusted as necessary; admin can be cyclical (3 wk on, 1 wk off) or continuous. In conjunction with a progestogen in women with uterus. Oral Prophylaxis of osteoporosis in postmenopausal women

Adult: 0.5 mg/day in cyclic regimen (23 days on and 5 days off). Oral Hypogonadism

Adult: 1-2 mg/day in a cyclic regimen for 3 wk on drug, followed by 1 wk drug-free. Intramuscular Prostate cancer

Adult: As valerate: ≥30 mg every 1-2 wk. Intramuscular Moderate to severe vasomotor symptoms associated with menopause

Adult: As cypionate: 1-5 mg every 3-4 wk; as valerate: 10-20 mg every 4 wk. In conjunction with a progestogen in women with uterus. Transdermal Moderate to severe vasomotor symptoms associated with menopause

Adult: Each patch delivers 0.025 mg/day: Initially, apply once wkly, adjust dose as necessary to control symptoms. Attempt to taper or discontinue treatment at 3-6 mth intervals. In conjunction with a progestogen in women with uterus. Transdermal Prophylaxis of osteoporosis in postmenopausal women

Adult: Each patch delivers 14 mcg/day. Apply patch once or twice wkly. Adjust dose by monitoring biochemical markers and bone mineral density. A 14-day course of progestogen is required in women with an intact uterus once every 6-12 mth. Intramuscular Hypogonadism

Adult: As valerate: 10-20 mg every 4 wk. As cypionate: 1.5-2 mg mthly. Vaginal Vulvular and vaginal atrophy

Adult: Insert 2-4 g/day of vag cream intravaginally for 2 wk, then reduce gradually to half the initial dose for 2 wk followed by a maintenance dose of 1 g 1-3 times/wk. Vaginal Postmenopausal vaginal atrophy

Adult: Insert a vag ring containing 2 mg of Progynova 21 and keep in place for 90 days. Vaginal Urogenital symptoms

Adult: Insert a vag ring containing 2 mg of Progynova 21 and keep in place for 90 days. Vaginal Atrophic vaginitis

Adult: Initial: Insert 1 tab (20 mcg) once daily for 2 wk.

Maintenance: Insert 1 tab twice wkly. Attempt to discontinue or taper medication at 3-6 mthly intervals.

Oral Prostate cancer (androgen dependent, inoperable, progressing)

Adult: 10 mg tid for at least 3 mth. Oral Moderate to severe vasomotor symptoms associated with menopause

Adult: 1-2 mg/day adjusted as necessary; admin can be cyclical (3 wk on, 1 wk off) or continuous. In conjunction with a progestogen in women with uterus. Oral Osteoporosis prophylaxis in postmenopausal women

Adult: 0.5 mg/day in cyclic regimen (23 days on and 5 days off). Oral Female hypoestrogenism (due to hypogonadism)

Adult: 1-2 mg/day. Intramuscular Palliative treatment of advanced prostatic cancer

Adult: As valerate: ≥30 mg every 1-2 wk. Intramuscular Moderate to severe vasomotor symptoms associated with menopause

Adult: As cypionate: 1-5 mg every 3-4 wk; as valerate: 10-20 mg every 4 wk. In conjunction with a progestogen in women with uterus. Intramuscular Female hypoestrogensim (due to hypogonadism, castration or primary ovarian failure)

Adult: As valerate: 10-20 mg every 4 wk. Transdermal Moderate to severe vasomotor symptoms associated with menopause

Adult: Each patch delivers 0.025 mg/day: Initially, apply once wkly, adjust dose as necessary to control symptoms. Attempt to taper or discontinue treatment at 3-6 mth intervals. In conjunction with a progestogen in women with uterus. Transdermal Osteoporosis prophylaxis in postmenopausal women

Adult: Each patch delivers 14 mcg/day. Apply patch once or twice wkly. Adjust dose by monitoring biochemical markers and bone mineral density. A 14-day course of progestogen is required in women with an intact uterus once every 6-12 mth. Vaginal Vulvular and vag Atrophy

Adult: Insert 2-4 g/day of vag cream intravaginally for 2 wk, then reduce gradually to half the initial dose for 2 wk followed by a maintenance dose of 1 g 1-3 times/wk. Vaginal Postmenopausal vag atrophy

Adult: Insert a vag ring containing 2 mg of Progynova 21 and keep in place for 90 days. Vaginal Urogenital symptoms

Adult: Insert a vag ring containing 2 mg of Progynova 21 and keep in place for 90 days. Vaginal Atrophic vaginitis

Adult: Initial: Insert 1 tab (20 mcg) once daily for 2 wk.

Maintenance: Insert 1 tab twice wkly. Attempt to discontinue or taper medication at 3-6 mthly intervals.

Active ingredients: Estradiol
Unit description, dosagePrice, USD
Tablet, Film-Coated; Oral; Estradiol Valerate 1 mg
Tablet, Film-Coated; Oral; Estradiol Valerate 2 mg
Tablet; Oral; Estradiol Valerate 1 mg
Tablet; Oral; Estradiol Valerate 2 mg
Tablets, Film-Coated; Oral; Estradiol Valerate 1 mg
Tablets, Film-Coated; Oral; Estradiol Valerate 2 mg
Tablets; Oral; Estradiol Valerate 1 mg
Tablets; Oral; Estradiol Valerate 2 mg

List of progynova 21 brand and generic drugs

Progynova TS
Patch; Topical; Estradiol Hemihydrate 50 mcg / 24 h
Proluton (Argentina, Ethiopia, Italy, Turkey)
Injectable; Injection; Progesterone 100 mg / ml
Prosu (Taiwan)
Prosu 2 mg x 2 x 10's, 100 x 10's, 1000's
Provames (France)
Tablet, Film-Coated; Estradiol Hemihydrate 1 mg
Tablet, Film-Coated; Estradiol Hemihydrate 2 mg
Tablets, Film-Coated; Estradiol Hemihydrate 1 mg
Tablets, Film-Coated; Estradiol Hemihydrate 2 mg
Reglovar
Replasyn
Rhoxal-Estradiol Derm 100
Patch; Topical; Estradiol Hemihydrate 8 mg
Ricifon
Riselle (Brazil, Czech Republic, Romania)
Ritsifon
Ronfase
Rontagel (Argentina)
Rozval (Colombia)
Sandoz Estradiol (Canada)
Sandoz Estradiol Derm (Canada)
Sandrena (Australia, Brazil, Chile, Italy, Mexico, Switzerland, United Kingdom)
Gel; Topical; Estradiol Hemihydrate 0.5 mg / dose
Gel; Topical; Estradiol Hemihydrate 1 mg / dose
Sandrena 1mg/g GEL / 28$ 11.39
1 mg x 1 g x 28's$ 11.39
Sandrena 1
Gel; Topical; Estradiol Hemihydrate 1 mg / dose
Sandrena Gel
SANDRENA GEL Granules/ Powder / 1mg/g (28 units)$ 11.39
Sandrena Gel 1 gm Gel$ 0.41
Sisare Gel
Sisare Mono
Gel; Topical; Estradiol 0.5 mg / dose
Gel; Topical; Estradiol 1 mg / dose
SK-Estrogens
Soldep
Sotipox
Sprediol (Italy)
Sterigin
Synapause-E3 (South Africa)
Tablet; Oral; Estriol Succinate
Syndiol
Systen (Austria, Belgium, Brazil, Bulgaria, Czech Republic, France, Italy, Luxembourg, Netherlands, Poland, Switzerland)
Patch; Topical; Estradiol 0.025 mg / 24 h
Patch; Topical; Estradiol 0.05 mg / 24 h
Patch; Topical; Estradiol 0.1 mg / 24 h
Patch; Topical; Estradiol 0.75 mg / 24 h
Thaïs (France)
Thaïs Sept (France)
Thais
Patch; Topical; Estradiol 100 mcg / 24 h

Show all Progynova 21 generic names
 
Privacy Policy
© 2003 - 2014 igenericdrugs.com All Rights Reserved
 
Disclamer